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To explore the genetic contribution to autistic spec-
trum disorders (ASDs), we have studied genomic
copy-number variation in a large cohort of families
with a single affected child and at least one unaf-
fected sibling. We confirm a major contribution
from de novo deletions and duplications but also
find evidence of a role for inherited ‘‘ultrarare’’ dupli-
cations. Our results show that, relative to males,
females have greater resistance to autism from
genetic causes, which raises the question of the
fate of female carriers. By analysis of the proportion
and number of recurrent loci, we set a lower bound
for distinct target loci at several hundred. We find
many new candidate regions, adding substantially
to the list of potential gene targets, and confirm
several loci previously observed. The functions of
the genes in the regions of de novo variation point
to a great diversity of genetic causes but also
suggest functional convergence.INTRODUCTION
Autism spectrum disorders (ASDs) are among the most geneti-
cally determined of developmental and cognitive abnormalities,
with concordance between identical twins reported at nearly
90% in some studies (Muhle et al., 2004; Rosenberg et al.,
2009). There is a strong gender bias, with much higher incidence
in males than in females, especially for higher-functioning
children (Newschaffer et al., 2007). Previous studies found
a higher incidence of new copy-number mutation in autistic chil-
dren from simplex (only one affected child) ASD families than in
typical children or in children from multiplex (multiple affected
children) ASD families (Marshall et al., 2008; Sebat et al., 2007;
see also Itsara et al., 2010). Based on these earlier findings, we
proposed a role for new (or de novo) germline variation in simplex
families, distinct from transmitted variation that might predomi-886 Neuron 70, 886–897, June 9, 2011 ª2011 Elsevier Inc.nate in multiplex families. Similar findings have been reported
for sporadic and inherited schizophrenia (Xu et al., 2008). Further
analysis of the incidence of male probands in multiplex families
led us to derive a risk function for the population and to propose
that much of ASD arises from de novo variants of strong pene-
trance and that some de novo variants of high penetrance are
transmitted by relatively asymptomatic carriers in a dominant
fashion (Zhao et al., 2007).
In a continuing effort to explore ASDs and to reveal the targets
of mutation, we have participated in a large study of simplex
families: the Simons Simplex Collection (SSC), consisting of
approximately 1000 families at the time of this analysis
(Fischbach and Lord, 2010). Families with only a single child on
the spectrum were recruited. In nearly all cases there was at
least one unaffected sibling, and multiplex families were
specifically excluded. We analyze copy-number variation
(CNV) in SSC families by comparative genomic hybridization
(Iafrate et al., 2004; Sebat et al., 2004), using the NimbleGen
HD2 2.1 million probe microarray platform (http://www.
nimblegen.com/products/cgh/wgt/human/2.1m/index.html) with
oligonucleotides optimized for both hybridization performance
and uniform genome coverage. An accompanying paper
(Sanders et al., 2011) also reports findings on the same set of
SSC families using a similar approach but different CGH plat-
forms, the Illumina 1M and 1M Duo microarrays.
Due to the size of the present study, we are better able than
before to assess the contribution of de novo CNVs to autism.
Because this study utilizes a CGH platform with greater than
twice than the number of unique probes than earlier published
studies of similar family number (Pinto et al., 2010), we can in
theory detect smaller regions of variation. Both de novo deletions
and duplications contribute substantially to ASDs, and overall we
find a greater number of regions at a finer scale than was previ-
ously possible. We also establish and estimate the contribution
of the transmission of ‘‘ultrarare’’ variants to ASDs, in particular
inherited duplications. These findings add substantially to the
list of ASD candidate genes. Our results also reveal the gender
bias of autism in greater depth and raise the puzzle of the fate
of female carriers. By considering the number and proportion
of variant loci that are recurrent, we are able to give a lower
bound on the total number of target loci where copy-number
Table 1. Composition of Sample Subpopulations
Total Valid HQ HQ Quads
family 915 887 787 510
children 1784 1721 1475 1020
autM 772 747 641 443
autF 117 111 93 67
sibM 428 414 343 238
sibF 467 449 398 272
aut 889 858 734 510
sib 895 863 741 510
CGH was performed on 915 families, with a total of 1784 children
(probands and unaffected siblings). Families with pedigree and/or gender
mismatches were removed, leaving 887 families (‘‘valid’’) comprising
1721 trios (defined as both parents and a single proband or unaffected
child). To facilitate some computations, a restricted set of 1475 trios
composed of only high-quality (‘‘HQ’’) hybridizations was used. For
another subset of computations, only HQ families with exactly one
affected child and one unaffected sibling (‘‘HQ quads’’) were considered.
The subset of families used in each analysis is indicated where appro-
priate. Children were tabulated by affected status and gender (e.g.,
‘‘autM,’’ ‘‘autF,’’ ‘‘sibM,’’ and ‘‘sibF’’).
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Role of Rare Genetic Variation and Gender in ASDsmutation can lead to the disorder. The functions of some of the
genes in the de novo rare and ultrarare variation are considered
briefly here and assessed in greater depth in an accompanying
paper (Gilman et al., 2011).
The focus of this work is on rare events, in fact, ‘‘rare’’ almost
to the point of uniqueness within the cohort. There are good
reasons for this, both theoretical and practical (Xu et al., 2008;
McClellan and King, 2010). The hypothesis that autism results
from an unfortunate combination of common low-risk variants
(Wang et al., 2009; Weiss et al., 2009) can be safely rejected.
More generally, it flouts reason to believe that mutations of
high penetrance would ever be common for a disorder that so
drastically reduces fecundity. On the other hand, all genomes
are under mutational pressure, and so constantly give rise to
many variants that will be under strong negative selection.
Some of this negative selection will not be readily apparent,
occurring in utero. The rest will manifest as infant mortality and
disorders of childhood (such as ASDs) and early adolescence.
Each individual variant will be rare—extremely so—as it expands
in the population only if it offers some compensatory advantage.
RESULTS
Study Design and Data Processing
The Simons Simplex Collection is being assembled at 13 clinical
centers, accompanied by detailed and standardized phenotypic
analysis. An ongoing study of the correlations between our
genetic findings and the phenotypic data is not included in the
present study. Families with single high-functioning probands,
usually with unaffected siblings, are preferentially recruited,
and families with two probands are specifically excluded (Fisch-
bach and Lord, 2010). Bloods, drawn from parents and children
(affected and unaffected), are sent to the Rutgers Cell Repository
(RUCDR) for DNA preparation. Blood DNAs (and a few rare
cases, EBV-immortalized DNAs) from nearly 1000 families (of
the 3000 planned) were sent to our group for processing and
analysis. Approximately one-tenth of the families we analyzed
are not yet officially in the SSC databases. DNA samples were
shipped to NimbleGen’s Icelandic facility, where two-color
hybridizations using a single reference male genome were per-
formed. SSC samples were labeled with Cy3, and the reference
was labeled with Cy5. Ninety-seven percent of families passed
gender and pedigree checks for all members and are called
‘‘valid’’ herein. Those are the only families considered in this
report. We define a trio as consisting of a mother, a father, and
a child, either affected or unaffected. If each member of a trio
has a hybridization that passes minimum quality thresholds
(see Experimental Procedures), that trio and its associated
hybridizations are called ‘‘high quality’’ (or ‘‘HQ’’). Out of 1721
valid trios from 887 families, 1475 (86%) are HQ. For conve-
nience, throughout this report we refer to the children with diag-
nosed ASDs as ‘‘probands’’ and to the children who do not have
ASDs as ‘‘sibs.’’ For purposes of statistical evaluation, we estab-
lish the ‘‘HQquads,’’ a subset of 510HQ families with exactly one
proband and one sib each.
The composition of the children and families for the various
subpopulations under study is summarized in Table 1. There
are roughly equal proportions of probands and sibs. The male-to-female ratio among the probands is 7:1, typical of high-func-
tioning ASDs (Newschaffer et al., 2007). We mention here the
observation (to be discussed later) that there are fewer male
sibs than female sibs.
Hybridization data underwent extensive processing before
determining segments of altered copy number (Experimental
Procedures, Supplemental Experimental Procedures, and Fig-
ure 1). We extracted signal and noise parameters from each
hybridization and used these for quality control and to model
integer copy-number states (Figure 2). For partitioning the
genome into intervals of constant copy number, we used KS
segmentation (Grubor et al., 2009). We also employed a trio-
based Hidden Markov Model (HMM) to build databases of
high-confidence events and transmissions. High-confidence
events in 1500 parents were used to compile a frequency table
of copy-number variation for all probes. We searched for de
novo events in the 1475 HQ trios, initially restricting evidence
to autosomal probes that did not have known extra mappings
to the human genome (hg18 build) outside the event region,
and probes that were rarely polymorphic in the high-confidence
parental database (i.e., present in no more than 5/1500 parents).
We compiled those events with high statistical significance of
being de novo (p value < 109), creating a ‘‘stringent’’ automated
list of 70 de novo events (Table S1, ‘‘stringent’’). Figure 3 illus-
trates the family probe ratio data for two typical de novo events,
a duplication and a deletion.
We then relaxed these probe restrictions to consider lower-
quality trios, probes on the X chromosome, probes with higher
frequencies of polymorphism (but never more than 20/1500
parents), and de novo events of lower significance (p value <
107). We curated the resulting list, accepting 24 additional de
novo events, creating a ‘‘relaxed’’ manual list (Table S1,
‘‘relaxed’’). All events on the stringent list passedmanual inspec-
tion and are included in the ‘‘relaxed’’ list. We sent samples forNeuron 70, 886–897, June 9, 2011 ª2011 Elsevier Inc. 887
Figure 1. Data Processing Pipeline
The main data processing pipeline for identifying de novo and transmitted rare copy-number variants in the SSC is shown in gray at left, and the support pipeline,
which includes quality control, is shown in white at right. Data sets are represented by boxes and computational processes by ovals. Raw ratio data were
normalized and segmented prior to trio analysis. Supporting processes were used to determine hybridization quality, to exclude gender and pedigree
mismatches, to establish probe filters, and to build models for various copy-number states.
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(Supplemental Experimental Procedures, Tables S1 and S2,
and Figure S1), and 54/54 of the successfully completed hybrid-
izations of trios confirmed calls of de novo events, giving us high
confidence that these calls are true positives. We have even
higher confidence on transmitted events, because of additional
evidence, namely the presence of the event in both a parent
and a child with nearly identical boundaries.
De Novo Variation
Our observations regarding de novo events are summarized
(Table 2), and the events themselves are detailed individually
(Table S1). In total, we observed 75 de novo events in 68
probands (7.9% of all probands) and 19 events in 17 sibs
(2.0% of all sibs). These observations are consistent with the888 Neuron 70, 886–897, June 9, 2011 ª2011 Elsevier Inc.findings of previous studies that probands have a higher burden
of de novo copy-number mutations (Marshall et al., 2008; Sebat
et al., 2007). We also observe that females with ASDs have
a higher frequency of de novo events than males (11.7% versus
7.4%, p value = 0.16) and that de novo deletions are
more frequent than duplications in male probands (39 to 22,
p value = 0.04).
We also looked at these data from the standpoint of gene
‘‘hits’’ (Table 3). We used RefSeq for gene and exon information,
omitting snRNAs. A CNV is considered to ‘‘hit’’ a gene when at
least one exon of the gene overlaps the CNV. Of the 75 de
novo events in probands, 61 hit genes, as did nine of the 19
events in sibs (p value = 0.006). There were a total of 953 genes
hit in de novo events in probands but only 59 in sibs. The differ-
ence was overwhelming when we looked only at genes involved
Figure 2. Noise Parameters and State Calls
Regions of common copy-number polymorphism in 3653 hybridizations were examined to validate the performance of signal and noise parameters. A commonly
deleted region of 150 kb (representing a total of 99 probes) is displayed, along with the adjacent 20 probes from each flank.
(A) Median log ratio on the interval as a function of the signal parameter xh. Magenta, red, and green curves correspond to the mean as predicted by the noise
model for the three copy-number states 0, 1, and 2, respectively. The highlighted region to the right of the dashed line shows the values obtained in the 100 worst
hybridizations.
(B and C) Probe log ratio values on the region for a subset of hybridizations. Experiments are sorted by the median probe ratio value of the polymorphic region.
(B) shows 100 hybs selected at random from the left side of (A). (C) shows the 100 worst hybs from the highlighted (rightmost) region of (A).
(D)(F) are as in (A)(C) for the noise parameter sh.
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De novo events in probands typically involved many more genes
than de novo events in sibs. Another disparity was evident by
gender; more genes were present in events from female
probands than in those from male probands. The median
number of genes in a de novo event in a female proband was
15.5, but only 2.0 in males, with a high significance (p value =
0.05) as determined by a rank-sum permutation test. All genes
hit by de novo events, whether in a proband or a sib, are listed
in detail in Table S3.
Most de novo events were unique. There were, however, 16
events in probands that overlapped at four distinct loci
(Table S4). We define events as ‘‘overlapping’’ if either the events
intersect or they both hit the same gene, andwe refer to the locus
at which they overlap as a ‘‘recurrent’’ locus. Ten of these over-
lapping events occurred at 16p11.2, both as deletions (six) and
as duplications (four). The incidence of 16p11.2 copy-number
events we observe is consistent with previous studies (Mefford
et al., 2009; Pinto et al., 2010; Weiss et al., 2008). Out of the ten
16p11.2 CNVs, all but one occur in a male, and—assuming the
incidence of the mutation is equal in males and females—this
observation implies gender bias in penetrance of the ASDpheno-
type at this locus.Weobserve a single instance of transmission ofthe 16p11.2 deletion from a mother (family 12010, Table S5).
Inheritance of duplications at this locus had been previously re-
ported in a number of cases of ASDs, but there are relatively
few reports of transmitted deletions linked to ASDs (Bijlsma
et al., 2009; Fernandez et al., 2010; Shinawi et al., 2010).
A notable recurrence occurs at 7q11.23, as a duplication at the
Williams-Beuren Syndrome (WBS) locus. Deletion at this locus is
associated with mental retardation, and—in contrast to ASDs—
the deletion is characterized by precocious verbal ability, avid
eye contact, and a highly sociable disposition (Merla et al.,
2010). A third recurrent locus at 16p13.2 contains USP7 (encod-
ing a deubiquitinase), an intriguing finding given existing links
between USP7 and the spinocerebellar ataxia type 1 (Hong
et al., 2002). The fourth occurs at the NIPA locus on 15q11.2,
a region in which CNVs have been previously associated with
ASDs as well as epilepsy and schizophrenia (de Kovel et al.,
2010; Mefford et al., 2010; Stefansson et al., 2008; van der
Zwaag et al., 2010). For reasons discussed later, we discount
the significance of this recurrence. A fifth recurrence, de novo
duplication on 16p13.11, occurs in both a proband and a sib
from different families. This is a known locus of instability,
wherein deletions but not duplications are thought to be associ-
ated with cognitive problems (Hannes et al., 2009). We observeNeuron 70, 886–897, June 9, 2011 ª2011 Elsevier Inc. 889
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Figure 3. Ratio Data for De Novo Events
(A and B) Two representative de novo events, one
duplication (A) and one deletion (B). In each panel,
the mother’s probe log ratio values appear in red,
the father’s in blue, and the proband’s in green.
Exons are shaded in green and purple, with colors
alternating by gene (with gene names indicated in
blue). Dashed horizontal lines show the mean
ratios for the copy-number states 0, 1, 2, 3, and 4,
as predicted by the noise parameters of the
proband’s hybridization. The boundaries of the
deletion are indicated by the dashed vertical lines.
The x axis gives the probe coordinates as an offset
to the number in the lower right of the respective
panel.
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ASD (family 11450, Table S5).
To study recurrence further, we looked at a recently published
study, which reported 56 de novo events in a mixed set of
simplex and multiplex autism trios (Pinto et al., 2010). We omit
ten of these because (1) they occur within regions that are
commonly polymorphic in our cohort; and (2) when these regions
are polymorphic, the polymorphisms are transmitted without
bias to probands and sibs (Table S6). Of the remaining 46 events
from that report, 12 events overlapped our set of de novo events
in probands, at six distinct loci. Counting both data sets in total,Table 2. Distribution of De Novo CNVs by Polarity and Gender
Counts of De Novo Events Children with De Novo Events
Combined Del Dup Combined Del Dup
autM 61 39 22 55 37 21
autF 14 7 7 13 7 6
sibM 10 3 7 9 3 6
sibF 9 6 3 8 5 3
aut 75 46 29 68 44 27
sib 19 9 10 17 8 9
In the set of valid trios (see Table 1), 75 discrete de novo CNVs were observed in 68 probands (7.9%),
unaffected siblings (2.0%). The frequency of de novo CNVs in affected females is 11.7%, as compared
affected females are evenly split between deletions and duplications (7:7), but in affected males, de
duplications (39:22).
890 Neuron 70, 886–897, June 9, 2011 ª2011 Elsevier Inc.recurrent de novo events were observed
at 12 distinct loci (Table S4, Figure 5).
Transmitted Variation
Collections of families with multiple
affected children will be significantly en-
riched for families at high risk of transmis-
sion. The SSC was designed to exclude
suchmultiplex families, maximizing chan-
ces to discover de novo mutations.
However, as most families are not large,
it must be expected that the SSC is
far from entirely depleted for families at
high risk. In fact, we estimate that fewer
than 15% of such high-risk families withtwo children, at least one with autism, would be excluded by
the study design, and fewer than 30% of those with three chil-
dren. Accordingly, we studied the SSC families for evidence of
transmitted risk factors.
We saw no statistically significant difference between
probands and sibs when we looked at total numbers of trans-
mitted copy-number events or the numbers of genes hit by trans-
mission (Table S7). We explored evidence for transmission
distortion of many individual common copy-number polymor-
phisms, but found no statistically significant signal when
adjusted for multiple hypotheses (data not shown).Frequency in Children
Combined Del Dup
7.4% 5.0% 2.8%
11.7% 6.3% 5.4%
2.2% 0.7% 1.4%
1.8% 1.1% 0.7%
7.9% 5.1% 3.1%
2.0% 0.9% 1.0%
whereas 19 de novo events were detected in 17
to 7.4% in the affectedmales. De novo events in
novo deletions are nearly twice as frequent as
Table 3. Breakdown of De Novo Gene Disruptions by Polarity,
Gender, and Gene Count
Gene Disruption
Count
Median Genes
per Event
Median Genes
per Child
Total Del Dup All Del Dup All Del Dup
autM 650 409 241 2 1 5.5 3 1 6
autF 303 125 178 15.5 9 26 19 9 27
sibM 33 0 33 1 0 4 2 0 4
sibF 26 2 24 0 0 7 0.5 0 7
aut 953 534 419 4 2 7 4 2 8
sib 59 2 57 0 0 4 1 0 4
Genes were considered ‘‘disrupted’’ when at least one exon of that gene
overlapped a de novo deletion or duplication. From the set of valid fami-
lies, a total of 953 genes were disrupted in probands. Only 59 genes were
disrupted in the unaffected siblings, all but two of whichwere within dupli-
cation events. Median gene counts were computed by event and by
child. There was a significant disparity between the median genes per
de novo CNV in affected males (2) compared to affected females (15.5).
Also notable in both affected males and females was the smaller median
number of genes disrupted in de novo deletions than in duplications.
Neuron
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restricted to extremely rare events (Xu et al., 2008). We limited
ourselves to the 510 HQ quads: families with high-quality data
and exactly one affected and one unaffected child. To minimize
false signal, we considered only events of at least 20 probes.
Operationally, we define the ‘‘family hit count’’ for each RefSeq
gene as the number of families in whichwe observe a transmitted
event that overlaps an exon of that gene. In Table S8 we list all
genes with a positive family hit count and provide counts for
each time a given gene had an exon within an event transmitted
to a sib or a proband.
We define an ‘‘ultrarare gene’’ as a gene with a family hit count
of one and then define an ultrarare event as an event that over-
laps at least one exon of an ultrarare gene. In other words, an
ultrarare event is one that hits at least one gene that is not hit
by any other transmitted event over the population of HQ quads.
The 458 ultrarare events are summarized in Table S9. These
events are further characterized by the gender of the recipient
children, their affected status, and by the pattern of transmission
(‘‘singly’’ transmitted, either to a proband or a sib, or ‘‘doubly’’
transmitted, to both). Additional features are listed, such asaut male
aut female
sib male
sib female
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deleons dupA Bparent of origin, the ultrarare genes overlapping the event, and
whether the event is a duplication or deletion. One strong asym-
metry is between the counts of ultrarare deletions (178) and
duplications (432), in excess of the overall bias in all transmitted
events (3119 deletions versus 3875 duplications, p value = 3 3
1015). Note that this bias for duplications is the opposite bias
seen for de novo events in male probands, for which deletions
exceed duplications.
For singly transmitted ultrarare events, we find a slight excess
of events going to the proband rather than the sib (Table 4). The
signal is even stronger when we consider the number of ultrarare
gene hits (p value = 0.23 for events, p value = 0.13 for genes). We
see no bias in families with female siblings, in keeping with the
hypothesis that females are less likely to display the symptoms
of ASDs. The entirety of the bias for singly transmitted events
is in those quad families for which the unaffected sibling is
male (p value = 0.05 for events, p value = 0.01 for genes). More-
over, doubly transmitted events occur more often when the sib is
female than male (p value = 0.09 for events, p value = 0.02 for
genes). Recalling that the SSC cohort excluded families with
two affected children, these transmission biases are joint and
independent evidence that there are fewer transmissions of
ultrarare events to a male sib than to the autistic child in our
cohort and support the hypothesis that a portion of ultrarare
transmission events are causal in males.
There appears to be no gender bias in the parent of origin of
ultrarare events. Overall, the sources of transmissions of ultra-
rare events were 233 from the fathers and 223 from the mothers.
For events that were transmitted but not to the unaffected male
siblings, the sources were 125 from the fathers and 125 from the
mothers. The possible implications for this observation will be
discussed later.Combining Data for De Novo and Transmitted CNVs
We combined evidence from all CNVs, exploring transmitted
events that overlap de novo events (Table S3). We also compiled
lists of transmitted events with boundaries similar to those found
in de novo events (Tables S5 and S10). Because ultrarare trans-
mitted events and de novo events are sparse data sets, we
cannot expect to draw strong conclusions for specific loci by
combining these data. Rather, in these tables one can find anec-
dotal information that informally raises or lowers the suspicion
that various loci are contributory. For example, transmission8 16 32 64
of genes hit
licaons Figure 4. Histogram of De Novo Gene Hits
Eighty-five children in the study had detectable de
novo lesions: 33 had duplications, 49 had dele-
tions, and three had both a deletion and a dupli-
cation. We determined the number of gene hits per
child and aggregated by affected status and
gender. The boundaries of the histogram bins are
log scaled.
(A) Distribution of de novo deletions. Gender and
affected status are shown in the box at upper right.
(B) Distribution of de novo duplications. Gender
and affected status are as in (A).
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Figure 5. Distribution of De Novo Events in
ASD Study Populations
A total of 75 de novo copy-number variants in
autistic children were found in this study (desig-
nated by ‘‘L’’ in the legend). These observations
were combined with the set of de novo CNVs
identified in an earlier study (indicated by ‘‘P’’) of
similar scale (Pinto et al., 2010). Ten of the CNVs
from the earlier study appeared to be common
variants against the background of the SSC, and
consequently were omitted (Table S6). Chromo-
somes are pictured with alternating dark and light
regions for each cytoband and aligned by
centromeres. Duplications are pictured above and
deletions below the respective chromosomal
locus. Events in males and females from the SSC
study (‘‘L’’) appear in blue and red, respectively.
Events in males and females from the Pinto et al.
(2010) study (‘‘P’’) appear in light blue and light red,
respectively. Green bars spanning chromosomes
indicate the positions of the 12 loci with recurrent
de novo events.
Table 4. Statistics on Ultrarare Transmissions
Single Transmissions Double Transmissions
Aut Sib P Value QuadF QuadM P Value
All HQ Quads
event 157 142 0.23 94 65 0.09
child 128 113 0.15 77 59 0.21
gene 359 293 0.13 276 122 0.02
QuadF
event 75 81 0.64
child 63 63 0.54
gene 150 176 0.73
QuadM
event 82 61 0.05
child 65 50 0.06
gene 209 117 0.01
Ultrarare events (see text and Table S9) from HQ quads were tabulated
and classified as either single transmissions (to one child only, whether
affected or unaffected) or double transmissions (to both children). All
HQ quad transmissions were further broken down into family type by
the gender of the unaffected sibling (‘‘QuadF’’ and ‘‘QuadM’’). Counts
are given for number of events, number of recipient children and number
of ultrarare gene disruptions. The p values were computed from 10,000
permutations and showed the strongest disparity for singly transmitted
events in families with male siblings. Doubly transmitted events occurred
disproportionately in families with female siblings.
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several related voltage-gated calcium channels (see next
section) but diminish suspicion for the loci at NIPA (15q11.2)
and NPHP1 (2q13). The latter loci appear to be mainly unstable,
and parental variants transmit equally to sibs and probands.
Rare Homozygous Deletions
Although our focus has been on rare variants that contribute to
phenotypes in a dominant fashion, it has been documented
that some autism can result from the combined action of reces-
sive alleles (Morrow et al., 2008). Therefore, we scanned the
genomes of probands and sibs looking for rare homozygous
deletions that hit both alleles. Two were found, both occurring
in probands (Figure S2). One disrupted COMMD1 (2p15) in
a female. Homozygous loss of this gene is implicated in copper
toxicosis in dogs (van De Sluis et al., 2002) but has not been
previously reported in humans. The deletion initially appeared
as a de novo event; the father, but not themother, carried a hemi-
zygous deletion. However, the boundaries of the homozygous
loss in the child matched those of the hemizygous loss in the
father precisely, which raised our suspicion that the child had
an instance of a rare but known occurrence of uniparental dis-
omy of chromosome 2 (Kotzot and Utermann, 2005). Further
analysis of chromosome 2 of the proband revealedmultiple small
regions of homozygosity and heightened our suspicion, which
was eventually confirmed (M. State, personal communication).
The event is not counted in our tables or statistics of de novo
events because there may be other homozygous recessive
mutations elsewhere on the father’s chromosome 2 that are
not copy-number variants.
The second rare homozygous deletion occurred in a male
proband and disrupted CACNA2D4 (12p13.33). Both parents
were in the hemizygous state. This gene encodes a voltage-
dependent calcium channel. Although there are no known
autism-related phenotypes associated with homozygous muta-892 Neuron 70, 886–897, June 9, 2011 ª2011 Elsevier Inc.tions in CACNA2D4 (Wycisk et al., 2006), defects in CACNA1C
are known to be the basis of Timothy syndrome, a rare disorder
with symptoms including autism. We observe a de novo two-
gene deletion disrupting CACNA1B, another voltage-gated
calcium channel, and a transmission of a rare variant of
CACNA1C (a disruptive intragenic duplication) in one family.
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We find de novo events in 8% of children with ASDs and only in
2% of their unaffected siblings, in keeping with other reports
(Marshall et al., 2008; Sebat et al., 2007). The observed
frequency of de novo events in children with autism from simplex
families that we observe in our present study is slightly lower than
that observed in our previous study (10%), despite the fact that
our discovery tools are much more powerful than before (Sebat
et al., 2007). This may be related to ascertainment biases in the
two studies. The simplex population from the first study may
have been based on larger families with a single proband, and
so may have had fewer cryptic multiplex families than are
undoubtedly present in the current study. Also, the present study
is biased to higher-functioning probands, and as a consequence,
there is a lower ratio of female probands than in our earlier study.
Observable de novo events are more frequent in females, so the
first study—which recruited a higher proportion of females—
contained a higher proportion of children with observable
events. Finally, the first study was smaller, and the de novo
events were not filtered with the same exacting care as in the
present study.
It is reasonable to infer that most of de novo copy-number
mutations are at least contributory to the disorder. Taken in isola-
tion, the observation is also compatible with another explana-
tion: that de novo mutation is evidence of genome instability,
the actual underlying causal condition. However, the latter
view is not consistent with a decreased association of de novo
mutation in multiplex autism, nor with additional observations
made in this report, namely duplication-deletion imbalances,
frequency and size imbalances in the de novo events by gender,
bias in transmission of ultrarare copy-number variation to
probands, and bias in transmission by gender.
To help form a genetic theory of the basis of autism, we find it
useful to provide a summary of observations in the form of lists of
observed biases, or ‘‘asymmetries.’’ These observations are
derived from both this study and the previous literature (Marshall
et al., 2008; Pinto et al., 2010; Sebat et al., 2007; Zhao et al.,
2007). We organize these observations, each made with varying
degrees of confidence, as follows. (1) There is a higher incidence
of de novo copy-number mutation in children with ASDs from
simplex families than in their siblings. (2) There is a higher
incidence of de novo copy-number mutation in children with
ASDs from simplex families than in children with ASDs from
multiplex families. (3) For transmitted rare variants, duplications
greatly outweigh deletions. (4) Deletions outweigh duplications
in de novo events in children with ASDs. (5) There is evidence
of transmission distortion for ultrarare events to children with
ASDs, and (6) this bias arises from families in which the sibling
is an unaffected male. (7) Females are less likely to be diagnosed
with ASDs than are males. (8) A higher proportion of females with
ASDs have detectable de novo copy-number events than do
males with ASDs, and the events are larger.
The asymmetries are readily explained by a plausible genetic
theory. De novo mutation of high penetrance contributes to
autism, more so in families of low risk than in families at high
risk. In the latter, transmission genetics plays a greater role.
Deletions are generally more likely to be harmful than duplica-tions. By selection, a mutation of recent vintage but carried by
an unaffected parent is thus more likely to be a duplication.
Females appear to be more resistant than males to developing
ASDs, and large-copy-number events are observed more
frequently in affected females because such events are more
harmful, because there are fewer target genes that induce
ASDs in females thanmales, or both; see also the accompanying
paper by Gilman et al. (2011) for independent evidence. Sexual
dimorphism in brain development may explain the relative lack
of females with ASDs. Relative to males, females have an accel-
erated timescale for a number of cognitive milestones; for
example, generally speaking their first words at an earlier age
(Richler et al., 2010; Roze et al., 2010). A quicker pace of devel-
opment might reflect a robustness that offers females
protection.
There is one asymmetry that is conspicuous by its absence,
a puzzle buried in the transmission data. If females are resistant
to ASDs and children with ASDs have reduced fecundity, then
simple genetic theory predicts that mothers would be more the
likely sources of a risk allele than fathers. But we see no bias in
the parent of origin among transmitted ultrarare events.
However, we cannot reject such a hypothesis based on the
observed data. There is insufficient power under reasonable
assumptions of the rate of observable contributory transmitted
CNVs (7%) and a strong bias toward transmission from mothers
of contributory events (75%). Moreover, we lack a longitudinal
study of high-functioning children with ASDs and cannot know
that males will display reduced fecundity. Nevertheless, the
fate of females with a risk genotype remains a puzzle worth
contemplating. Females with higher-risk genotypes may
encounter difficulties at later stages of their lives that manifest
as a different diagnostic category, or that reduces fecundity. If
true, the disorder would most likely be one with a gender bias
opposite that of ASDs, such as anorexia nervosa (Fairburn and
Harrison, 2003).
Our genetic theory of autism, as discussed above, largely
depends on dominant acting genetic variants of variable pene-
trance. We think the theory is sufficient to explain most of the
genetic basis of autism, both simplex andmultiplex, but certainly
not all. For example, the role of recessivemutations in individuals
from consanguineous marriages has been demonstrated
(Morrow et al., 2008). We have observed only a single case of
inheritance of a rare homozygous null state.
A striking finding of all the studies of de novo mutation in
children with ASDs is the apparent number of distinct target
loci. Even discounting 25% of events as incidental (based on
a 2% frequency in sibs and 8% in probands), there are a large
number of target regions and few recurrences. Only CNVs at
16p11.2 are present in more than 1% of cases (ten out of 858
children). We can make an estimate of the minimum number of
target regions by analysis of recurrence. Combining two large
studies (ours and that of Pinto et al., 2010), we observe 39 over-
laps at 12 recurrent loci in 121 events. Excluding the highly recur-
rent 16p11.2 locus (with 13 hits in the combined dataset) and
discounting one-quarter of the remaining 108 events as inci-
dental, we observe 11 recurrent loci in approximately 80 causal
events. If we assume a uniform rate of copy-number mutation,
we estimate the number of target loci at 250–300. However,Neuron 70, 886–897, June 9, 2011 ª2011 Elsevier Inc. 893
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this figure would be an underestimate of total targets. We derive
a similar estimate for target size by a completely different
method, based on many assumptions including the rate of new
mutations that damage a gene in humans (about one gene per
three births), the incidence of ASDs amongmales (approximately
1 in 100), a genetic model that predicts that about half of ASDs
result from new mutations (Zhao et al., 2007), and high pene-
trance of a select set of single mutational hits. The latter assump-
tion is based on the observation of dominant transmission in
multiplex families (Zhao et al., 2007).
An organismwill be vulnerable to a single mutational hit at only
a small subset of its genetic elements. We imagine that vulner-
able targets may arise by two distinct cellular mechanisms:
insufficient or uncorrectable dosage compensation resulting
from (for example) altered stoichiometry of protein complexes;
and monoallelic gene expression, which could result in subpop-
ulations of functionally null neurons, perhaps confined to specific
subtypes (Gimelbrant et al., 2007; Gregg et al., 2010).Manymore
gene products undoubtedly function on pathways related to the
vulnerable target genes, but these genes will very rarely be found
in genetic screens of the proband because of either functional
redundancy or the robustness of dosage compensation. The
conclusion that there are a huge number of potential targets
for ASDs is all but unavoidable.
Despite the large number of target loci we identify and the
small number of recurrent loci detected in this analysis, several
of the events that we find supplement previous studies. For
example, NRXN1 (encoding neurexin 1) is a well-established
candidate gene underlying ASDs as well as schizophrenia (Ching
et al., 2010; Kim et al., 2008; Pinto et al., 2010); the 44 kb deletion
in family 12119 extends the number of known ASD-causing
variants in the 2p16.3 region. Similarly, homozygous mutations
in ADSL lead to adenylosuccinate lyase deficiency (OMIM
#103050) and autistic features (Marie et al., 1999; Stone et al.,
1992); ADSL haploinsufficency (family 12224) may also lead to
an ASD phenotype. More recently, maternally inherited deletions
at the X-linked DDX53 locus (encoding a DEAD-box RNA
helicase of unknown function) have been linked to ASDs in males
(Pinto et al., 2010). The deletion ofDDX53 in amale proband from
family 12561 is the first known ASD-associated de novo muta-
tion at this locus. The linkage of the X chromosomal NLGN3
locus (encoding neuroligin 3) to ASDs has been somewhat
unclear, as this conclusion was based on a single maternally
inherited missense mutation that cosegregated with autistic
diagnoses in two brothers from one family (Jamain et al.,
2003). The 33 kb deletion in NLGN3 (family 11689) discovered
in this study provides the first independent confirmation for
a role of NLGN3 mutations in the pathogenesis of ASDs.
At the present time, target genes in most de novo events
cannot be known with certainty. First, mutations in any given
candidate loci, even the recurrent ones, might be coincidental
and unrelated to ASDs. Second, most events are large, disrupt-
ing more than one gene (and often dozens). Third, multiple genes
within an event might act in concert. Fourth, attempts by biolo-
gists to discern the true functional subsets of genes in candidate
loci cannot easily be subjected to rigorous statistical evaluation.
For this reason, we have attempted to perform automated func-894 Neuron 70, 886–897, June 9, 2011 ª2011 Elsevier Inc.tional network analysis in a companion paper (Gilman et al.,
2011). That study concludes that among the diversity there is
also evidence of functional convergence upon synaptogenesis,
axon guidance, and neuron motility.
Although the studies of Gilman et al. and others (Bill and
Geschwind, 2009; Pinto et al., 2010) argue for functional conver-
gence, there is ‘‘evidence’’ to support almost any mechanism.
Some potential targets encode proteins involved in neurotrans-
mitter metabolism (ABAT in family 11551), synaptic proteins
(NRXN1 and NLGN3, as mentioned above), and growth cones
(BAIAP2 in family 11186). But other candidate genes encode
proteins active in protein degradation pathways (USP7 in fami-
lies 11551 and 11168), in intracellular signaling such as catenins
(CTNNA3 in family 11705 and CTNND2 in family 12289), and in
theWNT pathways (WNT3 and WNT9B in family 11982). Others
encode proteins that participate in metabolism (ADSL in family
12224, as previously mentioned), inflammation (CSMD1 in family
11225), and possibly environmental detoxification (COMMD1 in
family 11482). Although a significant fraction of perturbed genes
converge on several well-defined processes, the causes of
autism are likely to be very diverse, and some causes may be
treatable. However, the diversity implies that a treatment for
one form of autism may be specific for only a narrow subset of
genotypes and have no value for the majority. Once the specific
genes mutated in ASDs are known with confidence, we can
begin to think with clarity about the problems specific to individ-
uals within categories of causation rather than attempting to
manage a conglomerate disorder.
To achieve this clarity, copy-number studies may not suffice.
Even with 3000 families, searching for large-scale deletions
and amplifications will be inadequate to define the majority of
mutational targets with the certainty that is required to further
deepen understanding of the disorder at the mechanistic level.
We expect that single genes will be frequent targets. If so, then
we calculate that identifying the recurrent targets of de novo
mutation by sequencing the exome from 3000 families will
provide the yield and certainty that is needed to identify conclu-
sively the genetic causes of ASDs.
EXPERIMENTAL PROCEDURES
An outline of the overall study design is shown in Figure 1. The institutional
review board of Cold Spring Harbor Laboratory approved this study, and
written informed consent from all subjects was obtained by SFARI.
System Noise Correction and Segmentation
Complete details for system noise correction follow those in Lee et al. (2011). In
brief, we used standard schema (local and Lowess normalization), and we also
performed self-self hybridizations (using multiple reference genomes)
throughout the course of the SSC analysis. Based on singular value decompo-
sition of the self-self data, wewere able to determine the principal components
of system noise and to minimize the distortion of genetic signal. We then used
KS segmentation (Grubor et al., 2009), which utilizes minimization of variance
to segment the data and Kolmogorov-Smirnov statistics to judge the signifi-
cance of the segments. The generation of noise parameters is detailed in the
Supplemental Experimental Procedures.
Pedigree and Gender Analysis
We identified a set of 974 copy-number variant regions (CNVRs) in which
cluster analysis allowed us to make genotyping calls for integer copy-number
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father, and mother) appear to have an inconsistency in inheritance. For each
pair of hybridizations, we then calculated two relatedness measures: the
Mean Square Sum of the difference in copy-number state between two indi-
viduals, and a measure of the degree of similarity between polymorphisms
present in the DNA profiles of two individuals (Glaubitz et al., 2003). For these
measures, the thresholds for relatedness were 0.425 and 0.35, respectively.
A family was flagged when more than 10% of CNVRs showed inconsistency
between at least one parent and a child. For reasons of pedigree, we excluded
24 families from further analysis.
We compared the gender of a person as determined by probes on the X and
Y with the information supplied in the SSC databases. If any member was
discordant, the entire family was excluded, for a total of 26 families. There
were two cases of Kleinfelter syndrome in unaffected siblings; these families
were considered valid.
Five-State Model
We used signal/noise parameters to determine probabilities of copy-number
states for segments from normalized ratio data (Supplemental Experimental
Procedures). In our analysis, we restricted the state space in two ways. First,
we assumed that the reference is in copy-number state 2. For uniquely
mapping autosomal probes, this was almost always the correct state. The
handful of regions where our reference genome was not in copy-number state
2 was filtered later for polymorphism frequency.
Our second assumption limited the test genome to five integer copy-number
states, 0 to 4. Assuming a reference copy state of 2, this provided a reasonable
range of variability in the test genome, more than sufficient for handling all but
a few highly polymorphic regions. With the signal/noise parameters and the
state model, we determined a distribution for the normalized ratio values at
each of the five states within each hyb. We refer to this as the five-state model.
CNV Database
For each hybridization, we applied the five-state model to determine the most
likely copy-number state for each interval in the KS segmentation. For each
segment, we determine the most likely copy state for each probe. If the
majority of the probes are in the 0 or 1 state, the segment is a potential deletion;
if the majority of the probes are in the 3 or 4 state, the segment is a potential
duplication. For a potential N-probe deletion, we apply a binomial distribution
to determine the likelihood of observingM or more probes in the 0 or 1 state if
the segment is really in copy state 2. An analogous procedure was used for
determining a p value for potential duplications. By applying a reasonable
threshold for the p value (less than 107), we established a database of
CNVs. This database served two main purposes: (1) identifying failed hybs
with too many segments; and (2) generating a probe-wise map of copy-
number polymorphisms over a set of 1500 high-quality parental hybridizations.
Quality Control
We used three parameters to determine the quality of a hyb: the number of
autosomal segments in the CNV database, the signal parameter xh, and the
noise parameter sh (Supplemental Experimental Procedures). The quality
measures for a trio are the maximum of the measures taken over the hybs of
the three members in the trio. We ranked the valid trios for each quality param-
eter and designated as HQ only those trios in the lower 95th percentile for all
three parameters. The effects of poor noise and signal parameters on the
ability to distinguish copy-number states are demonstrated in Figure 2.
Probe Mapping and Filtering
For a given KS segment, states were only computed for probes that passed
our filters. The first filter was the number of mappings of the probe sequence
in the genome (hg18 build). We excluded probes with more than two
mappings, resulting in the exclusion of 3% of the probes. Further, we only
considered probes with two mappings if the second mapping was to a site
within the segment. This ensured that most probes behaved according to
the five-statemodel. Our second filter was based on the frequency of polymor-
phism, or ‘‘population threshold.’’ If a probe was in a segment deemed ampli-
fied or deleted in five or more parents, we excluded that probe from our
analysis of the segment. This eliminated most regions where our referencegenome was not in the standard copy-number state and guarded against
cryptic de novo events, for which parents carry both a duplication and a dele-
tion of the same locus.
Mendel and De Novo Violation
To analyze trios for de novo mutations, we used KS segmentation of the child
and generated three five-state models, one for each member of the trio. For
each interval in the child’s segmentation, we determined the most likely
copy-number state for each probe. If the majority of the child’s probes were
most likely in the 0 or 1 state, the segment was flagged as a potential deletion
event. If they were most likely in the 3 or 4 state, the segment was flagged as
a potential duplication.
If the segment was flagged, we decided whether each probe was a ‘‘Mendel
violator.’’ A probe is a deletionMendel violator if the child probe ismost likely in
the 0 or 1 state and if both parents are most likely in the 2, 3, or 4 state. A probe
is a duplicationMendel violator if the child probe ismost likely in the 3 or 4 state
and if both parents aremost likely in the 0, 1, or 2 state. For each potential dele-
tion (duplication) segment, we recorded the total number of probes and the
number of deletion (duplication) Mendel-violating probes.
For each trio, we used the five-state model to simulate ratio data for all
125 trio states (0 to 4 for child, father, and mother.) Of the 125 states, 36 are
‘‘Mendel violator’’ states (child = 1, father = 2, mother = 2; child = 1, father =
2, mother = 3, etc.) and the remaining 89 trio states are ‘‘Mendel obedient’’
(child = 2, father = 2, mother = 2; child = 1, father = 1, mother = 2, etc.). For
each trio state, we compute the probability that a probe drawn from that distri-
bution is classified as a deletion (or duplication) Mendel violator. We apply that
probability to parameterize a binomial distribution. This allows us to determine
the likelihood that an N-probe segment in that trio state would generate M or
more probes classified as Mendel violators. The p value for an N-probe
segment with M Mendel violators is the maximum likelihood computed over
all Mendel-obedient states.
Stringent De Novo Discovery
We set a strict threshold for the Mendel violation p value of 109 such that in
500 trios, we expected less than one false positive. As previously indicated,
we also set a strict threshold for the population filter of no more than five
parents showing a lesion involving a given probe. This method identified
70 de novo copy-number events in 67 trios.
Relaxed De Novo Discovery
We performed manual curation, in which we relaxed the p value threshold to
107 and the population threshold to 20. This yielded 241 de novo candidate
(DNC) events in 216 children. For each DNC, we assessed a variety of informa-
tion such as family ratio data, modeled state means, population polymor-
phism, quantile quality scores, and systematic noise. A total of 91 events
passed curation, including all 70 stringent events. A full list of de novo events
and their method of discovery can be found in Table S1.
Given the limited size of the X and Y chromosomes, we chose not to auto-
mate de novo discovery over these chromosomes. We altered the five-state
model to use a reference copy-number state of 1 and modified the Mendel
violation rules for a probe to reflect the gender of the child and the parents.
We then manually inspected all segments with greater than 70% of the probes
reporting as Mendel violators. Using this method, we identified three X chro-
mosome de novo events (Table S1).
Transmitted CNVs
To identify transmitted copy-number events, we developed a 125-state HMM
that operates simultaneously on the normalized ratio data of the child, father,
and mother. To determine emission probabilities, we used the product of the
five-state model for each member of the trio. We limited the effect of isolated
failed probes by setting a minimum emission probability calibrated to the rate
of single probe outliers. Transition probabilities were computed from the
average CNV frequency based on KS segmentation. An additional penalty
was applied for entering a ‘‘Mendel-violating’’ state. We then employed the
Viterbi algorithm to find the most likely path through the state space. Restrict-
ing to events in which the child showed deletions or duplications, we then
determined whether any parent shared the event. For each of the eightNeuron 70, 886–897, June 9, 2011 ª2011 Elsevier Inc. 895
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a measure of support similar to that of Mendel violators. Worst-case false-
positive rates were determined and p values assigned to each transmitted
(and de novo) event using a binomial distribution.
Permutation Tests
To determine the statistical significance of asymmetries, we performed
random permutations of the data. Typically, we used 10,000 permutations
for each test. See Supplemental Experimental Procedures for more details.
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